Uploaded December 2024 | Updated September 2026, 1 week ago
At the 2024 RNDS, Dr. Linda Nguyen discussed the characteristics and outcomes of children with acute disseminated encephalomyelitis (ADEM), focusing on those with and without the MOG antibody [00:00:10]. She highlighted the clinical features, including vision changes and intracranial pressure differences, as well as MRI and spinal fluid findings [00:01:18]. The study included patients from the Children's Health in Dallas between 2017 and 2024, analyzing differences in age of onset, race, and hospitalization outcomes [00:02:58]. Dr. Nguyen emphasized the importance of early OCT testing and managing increased intracranial pressure in MOG-positive ADEM patients [00:13:46]. Concluding, she answered questions form the audience [00:16:00]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
You can view the presentation slides here:
files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Nguyen.pdf
00:00 Introduction to ADEM and MOG Antibody
01:18 Study Objectives and Methodology
02:58 Patient Demographics and Initial Findings
04:15 Clinical and Paraclinical Features
07:29 MRI and Cerebral Spinal Fluid Analysis
09:00 Hospital Course and Treatments
10:42 Long-term Outcomes and Follow-up
13:46 Summary and Conclusions
16:00 Q&A Session
At the 2024 RNDS, Dr. Linda Nguyen discussed the characteristics and outcomes of children with acute disseminated encephalomyelitis (ADEM), focusing on those with and without the MOG antibody [00:00:10]. She highlighted the clinical features, including vision changes and intracranial pressure differences, as well as MRI and spinal fluid findings [00:01:18]. The study included patients from the Children's Health in Dallas between 2017 and 2024, analyzing differences in age of onset, race, and hospitalization outcomes [00:02:58]. Dr. Nguyen emphasized the importance of early OCT testing and managing increased intracranial pressure in MOG-positive ADEM patients [00:13:46]. Concluding, she answered questions form the audience [00:16:00]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
You can view the presentation slides here:
files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Nguyen.pdf
00:00 Introduction to ADEM and MOG Antibody
01:18 Study Objectives and Methodology
02:58 Patient Demographics and Initial Findings
04:15 Clinical and Paraclinical Features
07:29 MRI and Cerebral Spinal Fluid Analysis
09:00 Hospital Course and Treatments
10:42 Long-term Outcomes and Follow-up
13:46 Summary and Conclusions
16:00 Q&A Session
